Literature DB >> 25584079

Mitochondrial protein alterations in a familial peripheral neuropathy caused by the V144D amino acid mutation in the sphingolipid protein, SPTLC1.

Scott E Stimpson1, Jens R Coorssen2, Simon J Myers3.   

Abstract

Axonal degeneration is the final common path in many neurological disorders. Subsets of neuropathies involving the sensory neuron are known as hereditary sensory neuropathies (HSNs). Hereditary sensory neuropathy type I (HSN-I) is the most common subtype of HSN with autosomal dominant inheritance. It is characterized by the progressive degeneration of the dorsal root ganglion (DRG) with clinical symptom onset between the second or third decade of life. Heterozygous mutations in the serine palmitoyltransferase (SPT) long chain subunit 1 (SPTLC1) gene were identified as the pathogenic cause of HSN-I. Ultrastructural analysis of mitochondria from HSN-I patient cells has displayed unique morphological abnormalities that are clustered to the perinucleus where they are wrapped by the endoplasmic reticulum (ER). This investigation defines a small subset of proteins with major alterations in abundance in mitochondria harvested from HSN-I mutant SPTLC1 cells. Using mitochondrial protein isolates from control and patient lymphoblasts, and a combination of 2D gel electrophoresis, immunoblotting and mass spectrometry, we have shown the increased abundance of ubiquinol-cytochrome c reductase core protein 1, an electron transport chain protein, as well as the immunoglobulin, Ig kappa chain C. The regulation of these proteins may provide a new route to understanding the cellular and molecular mechanisms underlying HSN-I.

Entities:  

Keywords:  Hereditary sensory neuropathy type 1; Mitochondria; Serine palmitoyltransferase long chain subunit 1; Ubiquinol-cytochrome c reductase core protein 1

Year:  2014        PMID: 25584079      PMCID: PMC4286568          DOI: 10.1007/s12154-014-0125-x

Source DB:  PubMed          Journal:  J Chem Biol        ISSN: 1864-6158


  28 in total

1.  Axonal mitochondrial transport and potential are correlated.

Authors:  Kyle E Miller; Michael P Sheetz
Journal:  J Cell Sci       Date:  2004-05-18       Impact factor: 5.285

2.  Top-down proteomics: enhancing 2D gel electrophoresis from tissue processing to high-sensitivity protein detection.

Authors:  Elise P Wright; Melissa A Partridge; Matthew P Padula; Victoria J Gauci; Chandra S Malladi; Jens R Coorssen
Journal:  Proteomics       Date:  2014-03-03       Impact factor: 3.984

3.  Mutations in the SPTLC1 protein cause mitochondrial structural abnormalities and endoplasmic reticulum stress in lymphoblasts.

Authors:  Simon J Myers; Chandra S Malladi; Ryan A Hyland; Tara Bautista; Ross Boadle; Phillip J Robinson; Garth A Nicholson
Journal:  DNA Cell Biol       Date:  2014-03-27       Impact factor: 3.311

Review 4.  The role of mitochondria in the pathogenesis of neurodegenerative diseases.

Authors:  G Manfredi; M F Beal
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

5.  Identification of p53 in mitochondria.

Authors:  Angelina V Vaseva; Ute M Moll
Journal:  Methods Mol Biol       Date:  2013

Review 6.  Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism.

Authors:  Kentaro Hanada
Journal:  Biochim Biophys Acta       Date:  2003-06-10

7.  Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells.

Authors:  Vadim N Dedov; Irina V Dedova; Alfred H Merrill; Garth A Nicholson
Journal:  Biochim Biophys Acta       Date:  2004-03-02

Review 8.  Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  L M Duffy; A L Chapman; P J Shaw; A J Grierson
Journal:  Neuropathol Appl Neurobiol       Date:  2011-06       Impact factor: 8.090

9.  Enhanced detergent extraction for analysis of membrane proteomes by two-dimensional gel electrophoresis.

Authors:  Matthew A Churchward; R Hussain Butt; John C Lang; Kimberly K Hsu; Jens R Coorssen
Journal:  Proteome Sci       Date:  2005-06-07       Impact factor: 2.480

10.  The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis.

Authors:  Beverley A Yard; Lester G Carter; Kenneth A Johnson; Ian M Overton; Mark Dorward; Huanting Liu; Stephen A McMahon; Muse Oke; Daphné Puech; Geoffrey J Barton; James H Naismith; Dominic J Campopiano
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

View more
  5 in total

1.  New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1.

Authors:  Heike Kölbel; Florian Kraft; Andreas Hentschel; Artur Czech; Andrea Gangfuss; Payam Mohassel; Chi Nguyen; Werner Stenzel; Ulrike Schara-Schmidt; Corinna Preuße; Andreas Roos
Journal:  Genes (Basel)       Date:  2022-05-17       Impact factor: 4.141

2.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

3.  Characterisation of the Mouse Cerebellar Proteome in the GFAP-IL6 Model of Chronic Neuroinflammation.

Authors:  Rustam Asgarov; Monokesh K Sen; Meena Mikhael; Tim Karl; Erika Gyengesi; David A Mahns; Chandra S Malladi; Gerald W Münch
Journal:  Cerebellum       Date:  2021-07-29       Impact factor: 3.847

4.  Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro.

Authors:  Emma R Wilson; Umaiyal Kugathasan; Andrey Y Abramov; Alex J Clark; David L H Bennett; Mary M Reilly; Linda Greensmith; Bernadett Kalmar
Journal:  Neurobiol Dis       Date:  2018-05-18       Impact factor: 5.996

5.  Comprehensive Computational Analysis of Protein Phenotype Changes Due to Plausible Deleterious Variants of Human SPTLC1 Gene.

Authors:  Tayyaba Sadaf; Peter John; Attya Bhatti
Journal:  Int J Mol Cell Med       Date:  2019-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.